Respiratory Disease Vaccine Market

Respiratory Disease Vaccine Market: Introduction
• Respiratory disease is a type of disease, which affects the lungs and other parts of respiratory system. It can be caused due to smoking tobacco, passive smoking, infection, asbestos, and other kinds of air pollution.
• Respiratory diseases include asthma, pulmonary fibrosis, pneumonia, chronic obstructive pulmonary disease (COPD), and lung cancer
Read Report Overview – https://www.transparencymarketresearch.com/respiratory-disease-vaccine-market.html
• COPD and asthma cause breathing difficult due to swelling of the air passage and blockage due to mucus. Certain vaccine-preventable diseases can cause swelling of air passage and lungs. The blend of the two can prompt pneumonia and different genuine respiratory ailments.
• Immunization is probably the most secure way to ensure a person’s wellbeing, regardless of whether he/she is taking prescribed medications. Vaccine reactions are normally mild and fade away on their own. Serious side effects are exceptionally uncommon.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77292
Key Drivers and Restraints of Global Respiratory Disease Vaccine Market
• According to the Forum of International Respiratory Societies (FIRS), 235 million people are suffering from asthma globally. Nearly, 10 million people develop tuberculosis annually, out of which 1.4 million succumb to the disease every year. Hence, rise in prevalence of respiratory disorders is a key factor driving the global market.
• According to the World Health Organization (WHO), nearly 200 million people are suffering from chronic obstructive pulmonary disease (COPD), of which 65 million are moderate to severe cases. Around 3 million people die annually, making it the third leading cause of death across the world. Increase in cases of COPD is anticipated to boost the growth of the global respiratory disease vaccine market.
• According to the World Health Organization (WHO), various respiratory disease vaccines are in pipeline and undergoing clinical trials. Rise in number of vaccines in pipeline is expected to propel the global respiratory disease vaccine market.
• However, governing bodies have stringent policies for approval of vaccines. This is likely to restrain the global respiratory disease vaccine market.
Request for Analysis of COVID-19 Impact on Respiratory Disease Vaccine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77292
North America to Lead Global Respiratory Disease Vaccine Market
• In terms of region, the global respiratory disease vaccine market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• North America dominated the global respiratory disease vaccine market, owing to government support for research & development in the field of vaccination and advanced health care infrastructure
• The market in Asia Pacific is projected to expand at the fastest CAGR during the forecast period due to cost-efficient research & development laboratories in the region and high prevalence of respiratory disorders
• Governments in Latin America and the Middle East are taking initiatives in research & development of vaccines, leading to moderate growth of the market during the forecast period
• The market in in Africa is likely to grow at a sluggish pace due to slow economic growth in countries in the region
Make an Enquiry before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=77292
Key Players Operating in Global Respiratory Disease Vaccine Market
Key players operating in the global respiratory disease vaccine market are:
• GlaxoSmithKline plc
• Pfizer, Inc.
• Merck Sharp & Dohme Corp.
• Sanofi
• Serum institute of India Private Limited
• Novavax, Inc.
• Emergent BioSolutions, Inc.
• CSL Limited
• INOVIO Pharmaceuticals
• Bavarian Nordic
• Mitsubishi Tanabe Pharma Corporation
More Trending Reports by Transparency Market Research –
Extracorporeal Membrane Oxygenation Machine Market: https://www.biospace.com/article/extracorporeal-membrane-oxygenation-machine-market-rising-awareness-about-the-benefits-to-drive-the-market-s-growth/
Virus Filtration Market: https://www.prnewswire.co.uk/news-releases/global-virus-filtration-market-to-expand-as-researchers-focus-on-improving-testing-technologies-tmr-877745218.html
Advanced Glycation End Products Market: https://www.prnewswire.com/news-releases/advanced-glycation-end-products-market-to-reach-us-2-76-bn-by-2031–finds-tmr-study-301461820.html
Placental Stem Cell Therapy Market Size: https://www.prnewswire.co.uk/news-releases/placental-stem-cell-therapy-market-to-surpass-us-4-4-bn-by-2030-underpinned-by-enormous-r-amp-d-in-cellular-therapies-and-regenerative-medicine-finds-tmr-study-862182963.html
Fluorine-18 Market: https://www.prnewswire.co.uk/news-releases/fluorine-18-market-to-exceed-us-3-bn-by-2030-surge-in-use-of-pet-ct-scan-in-oncology-spurs-demand-for-fdgs-notes-study-by-tmr-865401243.html
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/